Retigabine
id:
retigabine-179-3670069
title:
Retigabine
text:
Retigabine (INN) or ezogabine (USAN) is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. It was approved by the European Medicines Agency under the trade name Trobalt on March 28, 2011, and by the United States Food and Drug Administration (FDA), under the trade name Potiga, on June 10, 2011. Production was discontinued in June 2017. Retigabine works primarily a
brand slug:
wiki
category slug:
encyclopedia
description:
Anticonvulsant, which works as a potassium-channel opener
original url:
https://en.wikipedia.org/wiki/Retigabine
date created:
2009-03-27T14:28:47Z
date modified:
2024-09-04T21:09:46Z
main entity:
{"identifier":"Q2146170","url":"https://www.wikidata.org/entity/Q2146170"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/61/Retigabine2DCSD.svg","width":512,"height":276}
fields total:
13
integrity:
16